BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Gene Express Enters Into India Distribution Agreement With Biogenuix Medsystems Pvt. Ltd.


1/22/2009 1:22:32 PM

WILMINGTON, NC--(Marketwire - January 22, 2009) -

Gene Express Inc. announced today that it has entered into a Distribution Agreement with Biogenuix Medsystems Pvt. Ltd. for the distribution of Gene Express Inc's Standardized RT-PCR reagents (StaRT-PCR™) and research molecular diagnostic tools. The non-exclusive agreement provides Biogenuix with the rights to distribute in India.

Jonathan Rowe PhD, Chief Operating Officer for Gene Express Inc., stated, "This will be the first time that Gene Express' patented standardized gene expression technology will be made widely available to Indian researchers. By partnering with a valuable partner in Biogenuix, we are confident that the Gene Express tests and reagents will be widely accepted in the Indian research market."

Sundeep Amar, Director of Biogenuix Medsystems Pvt. Ltd., stated, "We are very optimistic about the potential of StaRT-PCR™ in India. This is the right time to enter the Indian molecular diagnostic & research market as there is a rapid growth in the installation base of RT-PCR platforms in the country."

Among the StaRT-PCR™ based research molecular tools are kits for Chronic Myelogenous Leukemia (bcr-abl), Lung Cancer Risk Prediction and Inflammation/Rheumatoid Arthritis. The reagents include a selection of more than six hundred StaRT-PCR™ internal standards.

About Biogenuix Medsystems Pvt. Ltd.

Biogenuix plays a key role as a marketer, market research & service provider to scientific & healthcare companies and professionals by offering unique solutions through its philosophy of innovation, quality, dependability and consistency. Biogenuix has long-term distribution and marketing agreements with more than 20 leading manufacturers of diagnostics, life-sciences, biopharma products and International marketing services companies. Biogenuix's portfolio includes a range of Specialized Diagnostic products as well as a large portfolio of antibodies, peptides,IHC slides, si-RNA's, microarray substrates and other regents. Biogenuix offers the most comprehensive range of Transplant Diagnostics products in India and exclusively represents One Lambda Inc, the pioneers and global leaders in transplant diagnostics and research products.

About Gene Express, Inc.

Gene Express, Inc. is a molecular diagnostic company that integrates personalized medicine into clinical care by enabling the generation of standardized, comparable and quality controlled data for molecular diagnostic testing. The Company's proprietary and patented StaRT-PCR™ (Standardized Reverse Transcription Polymerase Chain Reaction) platform technology for measuring gene expression levels in cells, clinical biopsies and blood is being used to develop proprietary molecular diagnostics and to develop the molecular diagnostics capabilities of other companies. The Company's $3 billion focus market for licensing and contract services includes the drug development, academic and molecular diagnostics segments. Additional information is available on the Company's website at www.geneexpressinc.com.

Any forecasts, plans, projections and other information contained in this press release describing events or results that may occur in the future are "forward-looking statements" as defined in the United States Private Securities litigation Reform Act of 1995. Forward-looking statements are subject to risks, uncertainties and important factors that are beyond the control of the Company that could cause actual results and events to differ materially from the results presently anticipated or projected. Readers are cautioned not to place undue reliance on these forward-looking statements and any such forward-looking statements are qualified in their entirety by reference to this cautionary statement. All forward-looking statements contained herein speak only as of the date of this release and are based on current expectations. The Company disclaims any obligation to update or revise any forward-looking statements.


Contact:
Gene Express Inc.
Gerald Vardzel
Email Contact
910-338-5058

Contact:
Biogenuix Medsystems Pvt. Ltd
Sundeep Amar
Email Contact
Phone- 0091-11-25612008
Fax- 0091-11- 45513884



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES